Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently released new information regarding a widespread Salmonella outbreak linked to cucumbers. Working alongside the Centers for Disease Control and Prevention …
FDA Updates on Salmonella Outbreak Linked to Cucumbers Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will co-host a public workshop focused on the development of clinical outcome assessments for …
FDA and NIH to Host Workshop on Brain-Computer Interface Devices Read More
WASHINGTON, D.C. — On Tuesday, the Food and Drug Administration (FDA) approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. This approval marks a major milestone in the fight …
FDA Approves Kisunla for Alzheimer’s Treatment, Marking Significant Progress Read More
WASHINGTON, D.C. — The FDA has broadened its advisory regarding Diamond Shruumz-brand chocolate bars, cones, and gummies following a recall initiated by Prophet Premium Blends, LLC. The recall, announced on …
FDA Expands Warning on Diamond Shruumz Products After Multi-State Illness Outbreak Read More
WASHINGTON, D.C. — On Tuesday, the Food and Drug Administration (FDA) announced it is revoking the regulation that allows brominated vegetable oil (BVO) to be used in food. This decision …
FDA Bans Brominated Vegetable Oil, Citing Health Risks Read More
WASHINGTON, D.C. — On Monday, the FDA’s Center for Devices and Radiological Health (CDRH) announced the continued expansion of its Total Product Life Cycle (TPLC) Advisory Program. This program, initially …
FDA Expands Total Product Life Cycle Advisory Program to Accelerate Medical Device Development Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that the national supply of cisplatin, a key cancer medication, now exceeds demand, ending a critical shortage that began …
FDA Announces End to National Shortage of Crucial Cancer Drug Cisplatin Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a warning to parents about the dangers of using benzocaine or lidocaine to treat teething pain in infants and …
FDA Warns Against Using Benzocaine and Lidocaine for Teething Pain in Children Read More WASHINGTON, D.C. — The FDA recently announced a new collaboration with the Bill and Melinda Gates Foundation aimed at developing breath-based diagnostic devices to detect infectious diseases in underserved populations. …
FDA Partners with Gates Foundation to Develop Breath-Based Diagnostics for Infectious Diseases Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval to Epkinly (epcoritamab-bysp), a new treatment option for adults with relapsed or refractory follicular lymphoma (FL). This …
FDA Grants Accelerated Approval to New Treatment for Relapsed Follicular Lymphoma Read More